A detailed history of Bard Financial Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Bard Financial Services, Inc. holds 88,890 shares of NVO stock, worth $7.77 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
88,890
Previous 20,665 330.15%
Holding current value
$7.77 Million
Previous $2.46 Million 330.24%
% of portfolio
1.26%
Previous 0.52%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$119.07 - $145.42 $8.12 Million - $9.92 Million
68,225 Added 330.15%
88,890 $10.6 Million
Q3 2024

Oct 04, 2024

SELL
$119.07 - $145.42 $9.11 Million - $11.1 Million
-76,500 Reduced 78.73%
20,665 $2.46 Million
Q2 2024

Jul 09, 2024

BUY
$122.71 - $146.91 $277,324 - $332,016
2,260 Added 2.38%
97,165 $13.9 Million
Q1 2024

May 06, 2024

SELL
$102.11 - $135.92 $252,722 - $336,401
-2,475 Reduced 2.54%
94,905 $12.2 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $234,372 - $281,551
2,670 Added 2.82%
97,380 $10.1 Million
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $4.14 Million - $9.09 Million
45,555 Added 92.68%
94,710 $8.61 Million
Q2 2023

Jul 11, 2023

SELL
$155.98 - $172.65 $257,366 - $284,872
-1,650 Reduced 3.25%
49,155 $7.95 Million
Q1 2023

Apr 26, 2023

SELL
$132.34 - $159.14 $198,510 - $238,709
-1,500 Reduced 2.87%
50,805 $8.09 Million
Q4 2022

Jan 25, 2023

SELL
$102.55 - $135.33 $89,731 - $118,413
-875 Reduced 1.65%
52,305 $7.08 Million
Q3 2022

Oct 26, 2022

BUY
$95.28 - $116.93 $23,820 - $29,232
250 Added 0.47%
53,180 $5.3 Million
Q2 2022

Jul 06, 2022

SELL
$103.24 - $121.81 $12,905 - $15,226
-125 Reduced 0.24%
52,930 $5.9 Million
Q1 2022

Apr 13, 2022

SELL
$93.1 - $112.54 $46,550 - $56,270
-500 Reduced 0.93%
53,055 $5.89 Million
Q4 2021

Jan 24, 2022

SELL
$95.88 - $117.08 $19,176 - $23,416
-200 Reduced 0.37%
53,555 $6 Million
Q3 2021

Oct 15, 2021

SELL
$84.42 - $106.62 $8,442 - $10,662
-100 Reduced 0.19%
53,755 $5.16 Million
Q2 2021

Jul 13, 2021

SELL
$67.66 - $84.76 $42,287 - $52,975
-625 Reduced 1.15%
53,855 $4.51 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $368,830 - $417,009
-5,500 Reduced 9.17%
54,480 $3.67 Million
Q4 2020

Mar 26, 2021

BUY
$63.89 - $73.8 $3.83 Million - $4.43 Million
59,980 New
59,980 $4.19 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bard Financial Services, Inc. Portfolio

Follow Bard Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bard Financial Services, Inc. with notifications on news.